THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
SAIKUMAR, POTHANA,SINGHA, PRAJJAL, KANTI
申请号：
EP14757801
公开号：
EP2961853A4
申请日:
2014.02.26
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The invention provides methods for classifying a cancer as susceptible to transmembrane prostate androgen induced (TMEPAI)-directed therapies, and methods for treating such cancers. The field of the invention pertains generally to medicine, pathology and oncology. More particularly, it addresses the treatment of breast cancer, such as triple-negative breast cancer, using a transmembrane prostate androgen induced (TMEPAI)-directed therapy.
